VCM
CMD

Vigilant Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Vigilant Capital Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-700
Closed -$25K – 357
2020
Q1 		$25K Hold
700
– – ﹤0.01% 247
2019
Q4 		$50K Hold
700
– – 0.01% 287
2019
Q3 		$52K Hold
700
– – 0.01% 246
2019
Q2 		$56K Buy
+700
New +$49.2K 0.01% 234

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vigilant Capital Management's CMD Position: Q2 2020 in Review

Vigilant Capital Management sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 700 shares — an estimated $25K sold.

Vigilant Capital Management first reported a position in CMD in Q2 2019 and held it in 4 quarters. The position peaked at $56K in Q2 2019. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

  • Vigilant Capital Management reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • Vigilant Capital Management sold 700 Cantel Medical Corporation shares in Q2 2020, an estimated $25K.
  • Vigilant Capital Management first reported a position in Cantel Medical Corporation in Q2 2019 and held it in 4 quarters.
  • Vigilant Capital Management's Cantel Medical Corporation position peaked at $56K in Q2 2019.
  • 210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Vigilant Capital Management's 13F filing for Q2 2020, filed 10 Jul 2020.